Clin2
NCT04218318Possibly a fitRecruiting

Stopping light therapy early in newborns with blood breakdown

Hemolytic Disease of NewbornNeonatal Hyperbilirubinemia

Part of Blood & lymphatic, Genetic & congenital, Immune system & allergy, Women’s health & pregnancy clinical trials.

This study looks for a safe threshold to stop the “light therapy” (phototherapy) in newborns who have jaundice caused by blood cell breakdown (hemolytic disease). It may help some babies avoid unnecessary extra days of treatment while still staying safe.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
84 people
Ages
1 hour to 2 weeks
Study type
Interventional

Who can take part

  • Your baby was born at 35 weeks or later (term or late-preterm).
  • Your baby has signs of blood breakdown (hemolysis), such as: positive DAT with blood group mismatch, and/or a hemoglobin drop of 2 g/dL within 24 hours.
  • Your baby does not have a major birth defect.
  • Your baby does not have a serious surgical problem.
  • Your baby does not have direct (conjugated) high bilirubin.
  • Your baby does not have sepsis (a serious body infection).

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06702241Recruiting· Phase 2/Phase 3
Light therapy for newborn jaundice

This trial tests different ways to give light therapy to newborns with jaundice. It compares different approaches to see which is best, and may help parents understand the most effective treatment for their baby.

Aalborg
NCT07674537Not yet recruiting
Jaundice treatment thresholds for very premature babies

This study looks at how hospitals decide when to start treatment for jaundice (a yellowing of the skin) in very premature babies. The aim is to find the safest and most effective way to use bilirubin levels to guide care and improve outcomes for your baby.

Groningen, Provincie Groningen
NCT07150494Not yet recruiting
A new score to assess jaundice severity in newborns

This study is looking at a new scoring system to help doctors quickly tell how severe jaundice is in newborns. The goal is to better decide when a baby needs stronger treatment like a blood exchange, so the right care can be given sooner.

NCT07694635Not yet recruiting
Predicting bilirubin rebound after phototherapy in newborns

This study looks at what happens to a newborn's bilirubin level (the substance that causes jaundice) in the 48 hours after light therapy (phototherapy) is stopped, to see if it goes back up. It aims to help predict which babies might need more treatment.

Istanbul, Sultangazi
NCT04246229Not yet recruiting
Skin-based jaundice measurement for newborns in light therapy

This study tests a device that measures jaundice level through the skin without needing a blood test. It is for newborns who need light therapy.

Zwolle, Overijssel
NCT07610811Recruiting
Foot Reflexology and Massage for Jaundiced Newborns

This study tests whether gentle foot reflexology and massage can help newborns with jaundice (high bilirubin levels in the blood) recover faster during light therapy treatment. Jaundice is common in newborns and is usually treated with special lights; this trial explores whether touch therapy might improve outcomes.

Kusadasi, Aydın

Hear when a new Neonatal Hyperbilirubinemia trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.